NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number
NO20090027L
NO20090027L NO20090027A NO20090027A NO20090027L NO 20090027 L NO20090027 L NO 20090027L NO 20090027 A NO20090027 A NO 20090027A NO 20090027 A NO20090027 A NO 20090027A NO 20090027 L NO20090027 L NO 20090027L
Authority
NO
Norway
Prior art keywords
vasoactive intestinal
intestinal peptide
new analog
analog
new
Prior art date
Application number
NO20090027A
Other languages
English (en)
Norwegian (no)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06
PCT/EP2007/056351 WO2008003612A2 (fr) 2006-07-06 2007-06-26 Nouveaux analogues de peptide vasoactif intestinal

Publications (1)

Publication Number Publication Date
NO20090027L true NO20090027L (no) 2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090027A NO20090027L (no) 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country Link
US (1) US20080096807A1 (fr)
EP (1) EP2041168A2 (fr)
JP (1) JP2009542593A (fr)
KR (1) KR20090027239A (fr)
CN (1) CN101484468A (fr)
AR (1) AR061825A1 (fr)
AU (1) AU2007271274A1 (fr)
BR (1) BRPI0714306A2 (fr)
CA (1) CA2656757A1 (fr)
CL (1) CL2007001956A1 (fr)
CR (1) CR10518A (fr)
EC (1) ECSP099029A (fr)
IL (1) IL196122A0 (fr)
MA (1) MA30590B1 (fr)
MX (1) MX2009000013A (fr)
NO (1) NO20090027L (fr)
PE (1) PE20081000A1 (fr)
RU (1) RU2009103811A (fr)
TW (1) TW200819139A (fr)
WO (1) WO2008003612A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2793715A1 (fr) 2010-04-30 2011-11-03 Sanwa Kagaku Kenkyusho Co., Ltd. Peptide permettant d'ameliorer la stabilite in vivo d'une substance physiologiquement active ou analogues et substance physiologiquement active et analogues presentant une amelioration de la stabilite in vivo
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
WO2014145718A2 (fr) * 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
EP3139949B1 (fr) * 2014-05-08 2020-07-29 Phasebio Pharmaceuticals, Inc. Compositions comprenant un protéine de fusion de vip-elp pour l'utilisation dans le traitement de la fibrose kystique
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
JP2000504676A (ja) * 1996-02-09 2000-04-18 エフ・ホフマン―ラ ロシュ アーゲー Ｖｉｐアナログの合成
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
EP1781693A2 (fr) * 2004-08-18 2007-05-09 Eli Lilly And Company Agonistes peptidiques selectifs du recepteur vpac2
WO2006042152A2 (fr) * 2004-10-08 2006-04-20 Forbes Medi-Tech (Research) Inc. Produits pharmaceutiques a base de polypeptides intestinaux vasoactifs

Also Published As

Publication number Publication date
AU2007271274A1 (en) 2008-01-10
CA2656757A1 (fr) 2008-01-10
WO2008003612A2 (fr) 2008-01-10
EP2041168A2 (fr) 2009-04-01
CR10518A (es) 2009-01-27
BRPI0714306A2 (pt) 2014-05-20
US20080096807A1 (en) 2008-04-24
RU2009103811A (ru) 2010-08-20
ECSP099029A (es) 2009-02-27
KR20090027239A (ko) 2009-03-16
JP2009542593A (ja) 2009-12-03
CN101484468A (zh) 2009-07-15
CL2007001956A1 (es) 2008-04-18
WO2008003612A3 (fr) 2008-02-28
MX2009000013A (es) 2009-01-23
PE20081000A1 (es) 2008-08-06
TW200819139A (en) 2008-05-01
IL196122A0 (en) 2011-08-01
AR061825A1 (es) 2008-09-24
MA30590B1 (fr) 2009-07-01

Similar Documents

Publication Publication Date Title
NO20090027L (no) Ny analog av vasoaktivt tarmpeptid
MX2009012968A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
MX2009013138A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
TW200708513A (en) Novel crystalline forms of tiotropium bromide
DK1718336T3 (da) Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme
WO2008149144A3 (fr) Polypeptides, domaines variables d'anticorps et antagonistes
WO2006117300A3 (fr) Formes cristallines de bromure de tiotropium
WO2008082613A3 (fr) Conjugués polymère-fraction à activité facteur ix comprenant une liaison dégradable
TW200738632A (en) Cannabinoid receptor modulators
MY153957A (en) Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates
WO2007076260A3 (fr) Agonistes de recepteur de farnesoide x
TW200724541A (en) Imidazoquinolines as lipid kinase inhibitors
HK1131790A1 (en) High affinity human antibodies to human il-4 receptor
WO2008070111A3 (fr) Procédés de préparation de (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et intermédiaires de celle-ci
WO2004050610A3 (fr) Modulateurs du recepteur de la melanocortine
WO2010149578A3 (fr) Nouveaux amides de biphényl- et phényl-pyridine
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
MX2011008799A (es) Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
EP3087988A3 (fr) Utilisation d'inhibiteurs de récepteurs de type toll dans la prévention et le traitement de l'hypercholestérolémie et de l'hyperlipidémie et de maladies apparentées
MX2009001534A (es) Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
WO2010048477A3 (fr) Procede ameliore de preparation de produits couples a partir de 4-amino-3-cyanoquinoleines utilisant des intermediaires stabilises
MX2009013829A (es) Composiciones terapeuticas y su uso.
WO2007079163A3 (fr) Antagonistes du recepteur de la prokineticine 1
TW200716566A (en) Prokineticin 2 receptor antagonists
NO20081428L (no) Tetrahydrokinolinoner og anvendelse derav som modulatorer av metabotrope glutamatreseptorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application